Providers - COTA Healthcare

Clarity

The insights hidden within your data can be uncovered
to illuminate a path to better cancer care

Oncology Provider

COTA’s data curation service and oncology analytics solution help oncology practices and cancer centers make sense of fragmented and often incomplete EHR data. Our award winning Real World Analytics solution (RWA) helps clinicians and researchers answer complex questions and gain insight into their institution’s patient population, treatment patterns and disease outcomes to bring clarity to cancer care.

Real World Analytics

cota-provider-video-preview

Advancing

COTA customers have unique access to our deeply curated and continually growing database of deidentified and contemporaneous patient data across 14 cancer types, with expansion to 5 additional cancer types by the end of the year. Our partners can leverage the individual datasets on an ad-hoc basis, and additionally explore broader access as a member of our newly-formed COTA Research Consortium — a cooperative network of NCI-designated Cancer Centers. As a member of the Research Consortium, centers will partner to develop research protocols to further advance the knowledge, understanding and use of RWD.

Latest

Beyond Drug Prices: Understanding The True Cost of Treatment with Dr. Rafael Fonseca

In this episode of Real World Talk, host Kevin Keogh talks to Dr. Rafael Fonseca, a hematologist who specializes in multiple myeloma, and Interim Director of the Mayo Clinic’s Cancer Center. They discuss the gulf between the idealized world of clinical trials and the reality experienced by patients with an incurable cancer like multiple myeloma — and how real world data can help bridge the gap.

The Evolving Relationship Between Real World Data and Clinical Trials with Nancy Dreyer and C.K. Wang

In this episode of Real World Talk, host Zoe Li talks to Nancy Dreyer, Chief Scientific Officer of IQVIA, and COTA’s own Chief Medical Officer, Dr. C.K. Wang. They discuss the interactions between real world data and clinical trials, and how the two approaches can complement each other.

Varian Medical Systems Invests in COTA, Inc. to Help Drive Faster, More Accurate Data-Driven Cancer Care

Varian has invested $20M in COTA. Together, the two companies will work to empower cancer clinics with curated RWD and analytics tools.

"In my opinion, COTA now has what is the single best analytic tool in the market for monitoring practice patterns and quality in oncology."

"Working with COTA has enabled us to have clear and accurate access to understanding patterns of patient care faster than we've ever had."

“Proving your value as a provider is a matter of wedding your outcomes and costs. Through our work with COTA, we're closer to being able to do this than we ever have been before."

"The goal is to standardize care. Standardization is essential to patient safety and the control of costs. COTA's unique capabilities and partnership model enable us, for the first time, to monitor this standardization efficiently."

Getting

How do we derive value from disorganized data?

Our approach makes sense of all the relevant aspects of the patient journey from your medical records – data in physician notes, pathology, radiology, surgical reports, genomic testing results and to develop a longitudinal patient record and comprehensive picture of care.

What is unique about COTA's data curation approach?

COTA maintains a highly sophisticated and multidisciplinary data curation approach. Our methodology was developed by oncologists with input from a team of informaticists, cancer outcomes researchers, and biostatisticians with the goal of unlocking data from both structured and unstructured sources. All of our data curation efforts occur on the COTA Abstraction Platform (CAP), which is an internally developed and proprietary platform that enables COTA to leverage technology as we scale our curation efforts. Data elements are standardized across sources and ontologies to create a single, structured dataset that covers the full longitudinal history of a patient’s clinical care. COTA’s extensive quality control and audit process ensures the data can be readily transformed into fit-for-purpose research grade datasets and occurs at every step in the curation process, from the point of data entry all the way through to data delivery. Additionally, our process includes inter-rater reliability scoring prior to abstraction as well as programmatic controls which detect clinical improbability at data ingestion. COTA can curate on-demand, longitudinal histories of your patient population to meet the full range of research and operational improvement interests at your center.

How is the organized data delivered?

Our easy-to-use data visualization tools display your data in the clearest, most impactful way. Data is also available in a variety of file formats to suit your preferences for additional data analysis.

How can real-world data help reduce variation and improve care and quality outcomes?

Our data lets you look deeply at performance and outcomes across your provider organization, so you can identify variation and take action to improve care quality and outcomes.

What is the COTA CNA?

Our numerical classification system clusters patients with clinically similar disease characteristics, so that you gain a clearer, fuller picture, and uncover insights that could impact treatment decisions and outcomes.

Let’s work together to transform cancer care.